CTCX Overview

Corporate Rebranding: Carmell Corporation has rebranded itself as Longevity Health Holdings, Inc., with a new trading symbol and logo, reflecting its focus on longevity and healthy aging while planning future expansions into diagnostics and nutrition.

Growth and Product Launches: Following the acquisition of Elevai Skincare, the company reported a 34% sales increase and plans to launch several new products in Q2 2025, expecting revenues of $3 to $4 million from its existing product pipeline.

Acquisition Announcement: Carmell Corporation has completed the acquisition of Elevai Skincare's skin and hair care business, involving approximately $1.1 million in stock, $57,000 in cash, and additional earnout considerations based on future sales.

Strategic Benefits: The acquisition is expected to enhance Carmell's product portfolio, expand its commercial reach, and improve cash flow, with a focus on leveraging synergies from the integration of Elevai's assets and team.

U.S. Stock Market Performance: U.S. stocks saw gains with the Nasdaq Composite rising over 1%, while the Dow and S&P 500 also increased. Notable stock movements included Cerence Inc. surging 66% and N2OFF, Inc. jumping 202% due to significant announcements.

Global Market Trends: European shares declined, with major indices like the STOXX 600 and Germany's DAX falling, while Asian markets showed mixed results, particularly with China's Shanghai Composite dropping 1.57%. The ISM manufacturing PMI in the U.S. rose to 49.3, exceeding expectations.

U.S. Stock Market Performance: U.S. stocks saw gains this morning, with the Dow Jones increasing by over 100 points, while the ISM manufacturing PMI rose to 49.3, exceeding market expectations.

Sector Movements and Notable Stocks: Information technology shares rose by 1.1%, whereas financial shares fell by 0.2%. Significant stock movements included Treasure Global Inc. surging 234% and HWH International Inc. dropping 38%.

Private Placement Announcement: Carmell Corporation has completed a private placement, raising $1.85 million by issuing 8,065,210 shares of common stock and warrants at $0.23 per share, with plans to use the proceeds for product development and strategic acquisitions.

Future Plans and Product Development: The company aims to enhance shareholder value through the commercialization of its bio-aesthetic products, including a new skincare line, while also preparing for the resale registration of the newly issued shares.

U.S. Stock Market Performance: U.S. stocks declined with the Dow Jones falling over 300 points, while energy shares rose by 1%. Notable declines included Tesla down 7% and Neumora Therapeutics dropping 81% after disappointing study results.

Economic Indicators: U.S. construction spending unexpectedly stalled in November, initial jobless claims decreased, and the S&P Global manufacturing PMI slightly declined, indicating mixed economic signals.